Enanta Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
14.11.25
/
50%
€10.60
Target price
14.11.26
€14.61
Performance (%)
25.47%
Price
06.03.26
€11.60
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ currently has a performance of 25.47%. This prediction currently runs until 14.11.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Enanta Pharmaceuticals Inc. | -2.521% | -2.521% |
| iShares Core DAX® | -6,02 % | -4,60 % |
| iShares Nasdaq 100 | 0,51 % | 0,16 % |
| iShares Nikkei 225® | -7,16 % | -2,21 % |
| iShares S&P 500 | -0,26 % | -0,84 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals (NASDAQ:ENTA) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $17.00 price target on the stock.
Ratings data for ENTA provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€11.50
06.08.24
06.08.24
€9.15
06.08.25
06.08.25
-47.83%
07.08.25
07.08.25
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.70
09.08.23
09.08.23
€12.75
09.08.24
09.08.24
-25.17%
10.08.24
10.08.24